Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
出版年份 2021 全文链接
标题
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
作者
关键词
-
出版物
JOURNAL OF INFECTIOUS DISEASES
Volume 224, Issue 11, Pages 1839-1848
出版商
Oxford University Press (OUP)
发表日期
2021-09-24
DOI
10.1093/infdis/jiab490
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients
- (2021) Jean-Rémi Lavillegrand et al. Annals of Intensive Care
- Attributes and predictors of long COVID
- (2021) Carole H. Sudre et al. NATURE MEDICINE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
- (2021) Ryan S Thwaites et al. Science Immunology
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- High-dimensional characterization of post-acute sequelae of COVID-19
- (2021) Ziyad Al-Aly et al. NATURE
- Post-acute COVID-19 syndrome
- (2021) Ani Nalbandian et al. NATURE MEDICINE
- Persistent symptoms and association with inflammatory cytokine signatures in recovered COVID-19 patients
- (2021) Sean Wei Xiang Ong et al. Open Forum Infectious Diseases
- Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients
- (2021) Qigao Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Long COVID in a prospective cohort of home-isolated patients
- (2021) Bjørn Blomberg et al. NATURE MEDICINE
- New-onset IgG autoantibodies in hospitalized patients with COVID-19
- (2021) Sarah Esther Chang et al. Nature Communications
- SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
- (2021) Michael J. Peluso et al. Science Advances
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Subacute Thyroiditis After Sars-COV-2 Infection
- (2020) Alessandro Brancatella et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- New-Onset Diabetes in Covid-19
- (2020) Francesco Rubino et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study
- (2020) José María Galván-Román et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Humoral Immune Response to SARS-CoV-2 in Iceland
- (2020) Daniel F. Gudbjartsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019
- (2020) Ekasit Kowitdamrong et al. PLoS One
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production
- (2020) Yuezhou Chen et al. CELL
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19
- (2020) Milad Sharifpour et al. PLoS One
- Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma
- (2020) Tania S Bonny et al. Open Forum Infectious Diseases
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18
- (2015) Stamatis Papathanasiou et al. NATURE MEDICINE
- TNF biology, pathogenic mechanisms and emerging therapeutic strategies
- (2015) George D. Kalliolias et al. Nature Reviews Rheumatology
- Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non–AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment
- (2014) Allan R. Tenorio et al. JOURNAL OF INFECTIOUS DISEASES
- Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
- (2014) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality
- (2014) Sergio Serrano-Villar et al. PLoS Pathogens
- Interleukin-6 Overexpression Induces Pulmonary Hypertension
- (2008) M. Kathryn Steiner et al. CIRCULATION RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search